VeriMomvalprooyl oligopeptide-33 est-il sûr pendant la grossesse ?
I could not find authoritative safety or classification data for an ingredient named 'valprooyl oligopeptide-33' in the major cosmetic/regulatory sources. No harmonised CLP classification, SCCS opinion, or CIR assessment for this exact name is available in my training knowledge; therefore default scoring is 0. If this ingredient is an acylated peptide containing a valproyl (valproic acid–derived) group, that parent (valproic acid / sodium valproate) is a known teratogen, but I have no confirmed evidence that this specific cosmetic ingredient is that derivative or that it releases valproic acid in vivo.
Related ingredients
Frequently asked questions
- valprooyl oligopeptide-33 est-il sûr pendant la grossesse ?
- I could not find authoritative safety or classification data for an ingredient named 'valprooyl oligopeptide-33' in the major cosmetic/regulatory sources. No harmonised CLP classification, SCCS opinion, or CIR assessment for this exact name is available in my training knowledge; therefore default scoring is 0. If this ingredient is an acylated peptide containing a valproyl (valproic acid–derived) group, that parent (valproic acid / sodium valproate) is a known teratogen, but I have no confirmed evidence that this specific cosmetic ingredient is that derivative or that it releases valproic acid in vivo.
- valprooyl oligopeptide-33 est-il sûr pendant l'allaitement ?
- No data located in the referenced authoritative sources for breastfeeding-specific effects of 'valprooyl oligopeptide-33'. In absence of documented systemic absorption or reproductive/breastfeeding data, default hazard/exposure scores remain 0. If the ingredient were to liberate valproic acid systemically, breastfeeding concerns would follow those for valproate, but that linkage is not established here.
- valprooyl oligopeptide-33 est-il sûr pour la peau de bébé ?
- No specific data for infants (0–3 yr) were found. By default there is no evidence of hazard or mechanism for this ingredient. Because infant skin has higher absorption potential for ingredients that are measurably absorbed in adults, I assign a conservative exposure increase of +1 only if the ingredient has any measurable dermal absorption; however, no data confirming adult absorption were located for this specific ingredient.
- Comment VeriMom évalue-t-il valprooyl oligopeptide-33 ?
- VeriMom évalue valprooyl oligopeptide-33 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à valprooyl oligopeptide-33 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à valprooyl oligopeptide-33 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.